Medicine

• Jobaaj Stories
• 16 Apr 2025

The Indian government Bans 35 Unsafe Combination Drugs to Protect Public Health

India Bans 35 Fixed-Dose Combination Drugs to Safeguard Public Health In a significant move to prot

• Jobaaj Stories
• 09 Apr 2025

Jets Prospect Chaz Lucius Retires at 21 Due to Ehlers-Danlos Syndrome

Chaz Lucius Retires from Hockey at 21 Due to Ehlers-Danlos Syndrome In a heartbreaking announcement

• Jobaaj Stories
• 07 Apr 2025

Trump’s Tariffs Crash Markets—$6 Trillion Wiped Out

Former U.S. President Donald Trump has doubled down on his tariff strategy, dismissing fears over co

• Jobaaj Stories
• 04 Apr 2025

Dr. Oz Heads CMS: Controversial Choice Shakes US Healthcare

Dr. Oz Confirmed to Lead CMS: A Controversial Appointment The US Senate's confirmation of Dr. M

• Jobaaj Stories
• 21 Mar 2025

Mounjaro in India: Hope for Obesity, But at What Cost?

Eli Lilly's Mounjaro in India: Hope and Concerns for Weight Loss Eli Lilly's Mounjaro, a gr

• Jobaaj Stories
• 21 Mar 2025

Mounjaro in India: Weight-Loss Hope or Health Debate?

Eli Lilly's Mounjaro: A Weight-Loss Drug in India Eli Lilly's Mounjaro, a groundbreaking we

• Jobaaj Stories
• 05 Mar 2025

Urgent Recall: Boots Paracetamol Mislabeled as Aspirin

Boots Paracetamol Recall: What You Need to Know Boots has issued an urgent recall of its own-brand

• Jobaaj Stories
• 04 Feb 2025

World Cancer Day: Unite Against Cancer, Globally and Locally

World Cancer Day: United Against a Global Threat Every February 4th, World Cancer Day unites us in

• Jobaaj Stories
• 01 Aug 2023

Sneh Desai: Empowering Lives as India’s Influential Life Coach, Inspiring 21 Lakh Globally

Suppose, you are living a completely normal life and suddenly it all falls apart. Today, whenever we

• Jobaaj Stories
• 10 May 2023

Pharmeasy reports positive cash flow in April

Pharmeasy, India’s largest online medical platform, has reportedly seen positive cash flows in